Ionis CEO Stanley Crooke at the Carlsbad company’s office. Ionis drug Tegsedi recently won U.S. Food and Drug Administration approval. File Photo by Jamie Scott Lytle

Ionis CEO Stanley Crooke at the Carlsbad company’s office. Ionis drug Tegsedi recently won U.S. Food and Drug Administration approval. File Photo by Jamie Scott Lytle

photo

Research Assistant Andres Berdeja works at one of the Ionis labs in Carlsbad. File photo by Jamie Scott Lytle

Ionis Pharmaceuticals’ drug for a rare genetic disorder recently gained regulatory approval, a relief to investors worried about a denial, and pitting the company against Alnylam Pharmaceuticals...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129